ACTI.ST
Price:
$0.162
Market Cap:
$173.85M
Active Biotech AB (publ), a biotechnology company, develops pharmaceutical products the treatment of oncology and immunology diseases in Sweden. It is developing Tasquinimod, a small molecule immuno-modulator, which is in Phase Ib/IIa clinical trial to treat multiple myeloma; Laquinimod, an immunomodulator that is in phase I clinical trial for the treatment of inflammatory eye disorders, including uveitis; and Naptumomab, an anti-cancer immunotherapy, which is in phase Ib/II clinical trial to treat patients with advanced solid tumors. The company has a licensing agreement with NeoTX Therapeutics Ltd. for the development and commercialization of Naptumomab for cancer immunotherapy. Active Bio...[Read more]
Industry
Biotechnology
IPO Date
2003-12-19
Stock Exchange
STO
Ticker
ACTI.ST
According to Active Biotech AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -3.24. This represents a change of 87.48% compared to the average of -1.73 of the last 4 quarters.
The mean historical PE Ratio of Active Biotech AB (publ) over the last ten years is -2.21. The current -3.24 PE Ratio has changed 14.59% with respect to the historical average. Over the past ten years (40 quarters), ACTI.ST's PE Ratio was at its highest in in the December 2017 quarter at -0.28. The PE Ratio was at its lowest in in the June 2019 quarter at -8.06.
Average
-2.21
Median
-1.94
Minimum
-4.81
Maximum
-0.30
Discovering the peaks and valleys of Active Biotech AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 682.50%
Maximum Annual PE Ratio = -0.30
Minimum Annual Increase = -74.75%
Minimum Annual PE Ratio = -4.81
Year | PE Ratio | Change |
---|---|---|
2023 | -1.21 | -29.88% |
2022 | -1.73 | -28.67% |
2021 | -2.42 | -37.18% |
2020 | -3.86 | -5.67% |
2019 | -4.09 | -14.96% |
2018 | -4.81 | 682.50% |
2017 | -0.61 | -71.50% |
2016 | -2.16 | 150.82% |
2015 | -0.86 | 189.52% |
2014 | -0.30 | -74.75% |
The current PE Ratio of Active Biotech AB (publ) (ACTI.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-1.79
5-year avg
-2.66
10-year avg
-2.21
Active Biotech AB (publ)’s PE Ratio is greater than BioInvent International AB (publ) (-7.23), greater than Orexo AB (publ) (-3.62), less than Alligator Bioscience AB (publ) (-2.02), less than Swedish Orphan Biovitrum AB (publ) (31.74), less than Anoto Group AB (publ) (0.71),
Company | PE Ratio | Market cap |
---|---|---|
-7.23 | $2.96B | |
-3.62 | $378.95M | |
-2.02 | $501.82M | |
31.74 | $111.69B | |
0.71 | $53.26M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Active Biotech AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Active Biotech AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Active Biotech AB (publ)'s PE Ratio?
How is the PE Ratio calculated for Active Biotech AB (publ) (ACTI.ST)?
What is the highest PE Ratio for Active Biotech AB (publ) (ACTI.ST)?
What is the 3-year average PE Ratio for Active Biotech AB (publ) (ACTI.ST)?
What is the 5-year average PE Ratio for Active Biotech AB (publ) (ACTI.ST)?
How does the current PE Ratio for Active Biotech AB (publ) (ACTI.ST) compare to its historical average?